These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

683 related items for PubMed ID: 10065257

  • 21. Interventions for minimal change disease in adults with nephrotic syndrome.
    Palmer SC, Nand K, Strippoli GF.
    Cochrane Database Syst Rev; 2008 Jan 23; 2008(1):CD001537. PubMed ID: 18253993
    [Abstract] [Full Text] [Related]

  • 22. Minimal change disease in pregnancy.
    Lo JO, Kerns E, Rueda J, Marshall NE.
    J Matern Fetal Neonatal Med; 2014 Aug 23; 27(12):1282-4. PubMed ID: 24102437
    [Abstract] [Full Text] [Related]

  • 23. Prognostic indicators and treatment of childhood IgA nephropathy.
    Hogg RJ.
    Contrib Nephrol; 1995 Aug 23; 111():194-9; discussion 199-200. PubMed ID: 7758342
    [No Abstract] [Full Text] [Related]

  • 24. [Therapy of the nephrotic syndrome in children].
    Linneweh F.
    Minerva Med; 1973 Oct 27; 64(76):4007-9. PubMed ID: 4764071
    [No Abstract] [Full Text] [Related]

  • 25. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 27; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 26. Fibrillary glomerulonephritis: early diagnosis associated with steroid responsiveness.
    Dickenmann M, Schaub S, Nickeleit V, Mihatsch M, Steiger J, Brunner F.
    Am J Kidney Dis; 2002 Sep 27; 40(3):E9. PubMed ID: 12200826
    [Abstract] [Full Text] [Related]

  • 27. Nephrotic syndrome in childhood: diagnosis and management.
    Maier BA, Chan JC.
    Va Med; 1979 Jan 27; 106(1):33-40. PubMed ID: 419835
    [Abstract] [Full Text] [Related]

  • 28. Cyclosporine treatment of nephrotic syndrome in children.
    Brodehl J, Hoyer PF, Oemar BS, Helmchen U, Wonigeit K.
    Transplant Proc; 1988 Jun 27; 20(3 Suppl 4):269-74. PubMed ID: 3381282
    [No Abstract] [Full Text] [Related]

  • 29. [Minimal-change disease with mesangial IgA deposits associated with Sjogren syndrome].
    Mon C, Sánchez Hernández R, Fernández Reyes MJ, Estébanez C, Ortiz M, Alvarez-Ude F, Mampaso F.
    Nefrologia; 2002 Jun 27; 22(4):386-9. PubMed ID: 12369132
    [Abstract] [Full Text] [Related]

  • 30. Blood pressure in children with minimal change nephrotic syndrome during oedema and after steroid therapy: the influence of familial essential hypertension.
    Kontchou LM, Liccioli G, Pela I.
    Kidney Blood Press Res; 2009 Jun 27; 32(4):258-62. PubMed ID: 19752575
    [Abstract] [Full Text] [Related]

  • 31. Renal biopsy in a child with nephrotic syndrome.
    Meleg-Smith S, Krane NK.
    J La State Med Soc; 1997 Jul 27; 149(6):239-40. PubMed ID: 9231626
    [Abstract] [Full Text] [Related]

  • 32. Kimura disease: a case report and review of the Chinese literature.
    Wang DY, Mao JH, Zhang Y, Gu WZ, Zhao SA, Chen YF, Liu AM.
    Nephron Clin Pract; 2009 Jul 27; 111(1):c55-61. PubMed ID: 19052471
    [Abstract] [Full Text] [Related]

  • 33. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
    Aksu N, Türker M, Erdoğan H, Ozinel S, Kansoy S.
    Turk J Pediatr; 1999 Jul 27; 41(2):225-30. PubMed ID: 10770662
    [Abstract] [Full Text] [Related]

  • 34. [Verification of indications for kidney biopsy in children with steroid-dependent nephrotic syndrome].
    Idczak-Nowicka E, Ksiazek J, Kryński J, Wyszyńska T.
    Pediatr Pol; 1996 Aug 27; 71(8):679-83. PubMed ID: 8927471
    [Abstract] [Full Text] [Related]

  • 35. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S.
    J Med Assoc Thai; 2005 Nov 27; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [Abstract] [Full Text] [Related]

  • 36. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL, Shkerina LI, Shilov EM.
    Klin Med (Mosk); 2005 Nov 27; 83(10):48-50. PubMed ID: 16320847
    [Abstract] [Full Text] [Related]

  • 37. Nephrotic syndrome: minimal change disease.
    Aziz F, Qureshi AM.
    J Ayub Med Coll Abbottabad; 2001 Nov 27; 13(4):35-40. PubMed ID: 11873430
    [No Abstract] [Full Text] [Related]

  • 38. [Current therapy of nephrotic syndrome].
    Wegmüller E.
    Schweiz Med Wochenschr; 1984 Mar 17; 114(11):374-80. PubMed ID: 6710108
    [Abstract] [Full Text] [Related]

  • 39. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis.
    Al-Khader AA, Lien JW, Aber GM.
    Clin Nephrol; 1979 Jan 17; 11(1):26-30. PubMed ID: 428152
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.